RecruitingNCT06871683

ClotTriever® Thrombectomy System Use-Result Survey in Japan


Sponsor

Inari Medical

Enrollment

100 participants

Start Date

Feb 17, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this survey is to determine the safety and efficacy of the ClotTriever Thrombectomy System under daily clinical practice after marketing approval in Japan. This device was designated as a subject of use results evaluation at the time of application for manufacturing and marketing approval.


Eligibility

Inclusion Criteria1

  • This is an all-comers survey of all patients treated with ClotTriever® Thrombectomy System in Japan.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEClotTriever® Thrombectomy System

ClotTriever® Thrombectomy System use for treatment of patients with deep vein thrombosis with acute severe symptoms.


Locations(13)

Chiba University Hospital

Chuo, Chiba, Japan

Ota Memorial Hospital

Ōta, Gunma, Japan

St. Marianna University Hospital

Kawasaki, Kanagawa, Japan

National Cerebral and Cardiovascular Center

Suita, Osaka, Japan

Asahikawa Medical Hospital

Asahikawa, Japan

Asahi General Hospital

Chiba, Japan

Nozaki Tokushukai Hospital

Daitō, Japan

Shonan Kamakura

Kanagawa, Japan

Kyoto Katsura Hospital

Kyoto, Japan

Nara City Hospital

Nara, Japan

Osaka Police Hospital

Osaka, Japan

Mitsui Memorial Hospital

Tokyo, Japan

Mie University

Tsu, Japan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06871683


Related Trials